Split with brother stands, but Shivinder looks to bury the hatchet via mediation Shivinder further added that in case the mediation falls through, he intends to reassess and start a fresh action against his brother
Plan to add about 1,000-1,200 beds over the next 3-4 years: Fortis Healthcare MD & CEO "250 beds are going to come on line by the end of this financial year itself and those will bring a growth rate of about 10 percent," Ashutosh Raghuvanshi, MD and CEO of Fortis Healthcare said
Malvinder Singh, former Fortis Healthcare promoter, arrested Malvinder Singh and Godhwani are accused of laundering money, punishable under sections 3 and 4 of the Prevention of Money Laundering Act.Both Singh, Godhwani will be produced before a metropolitan magistrate in the prison, when the ED is likely to seek their custodial interrogation
In Singh brothers’ case, Delhi police will have to find where all the money has flown Investigating agencies have a task at hand to find out the money trail -- where it had flown and who were the end beneficiaries
September quarter earnings: 10 stocks likely to more than double PAT on YoY basis Auto, corporate banks, telecom, and metals are likely to post profit contraction or losses. There is likely to be a sharp slowdown in IT, say experts.
Stocks in the news: Bharat Electronics, Monsanto, Bayer Crop, Andhra Bank, Prabhat Dairy, Canara Bank Bharat Electronics | Monsanto India | Bayer Crop | Andhra Bank and Indian Bank are stocks which are in news today.
Ashutosh Raghuvanshi new CEO at Fortis (Former Narayana Hrudalaya old timer for 2 decades) has shared his turnaround plan including selling away non-core assets & bringing cost efficiencies & fresh cash infusion.
Fortis Healthcare posts Q1 profit at Rs 67.8 crore helped by strong operational performance The net profit in Q1FY20 was also aided by a reduction in the cost of borrowings and the elimination of hospital service fee due to the acquisition of RHT assets.
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.